We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
Medical Properties (MPW - Free Report) ended the recent trading session at $4.15, demonstrating a -1.89% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.61%. Elsewhere, the Dow gained 0.49%, while the tech-heavy Nasdaq added 0.95%.
Coming into today, shares of the health care real estate investment trust had lost 8.04% in the past month. In that same time, the Finance sector gained 2.14%, while the S&P 500 gained 3.85%.
The investment community will be closely monitoring the performance of Medical Properties in its forthcoming earnings report. The company is expected to report EPS of $0.13, down 43.48% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $228.55 million, reflecting a 14.26% fall from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.55 per share and revenue of $919.34 million. These totals would mark changes of -31.25% and -7.65%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Medical Properties. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, there's been a 2.35% fall in the Zacks Consensus EPS estimate. Medical Properties presently features a Zacks Rank of #3 (Hold).
Looking at valuation, Medical Properties is presently trading at a Forward P/E ratio of 7.64. This denotes a discount relative to the industry average Forward P/E of 11.41.
The REIT and Equity Trust - Other industry is part of the Finance sector. This group has a Zacks Industry Rank of 156, putting it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Stock Sinks As Market Gains: What You Should Know
Medical Properties (MPW - Free Report) ended the recent trading session at $4.15, demonstrating a -1.89% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.61%. Elsewhere, the Dow gained 0.49%, while the tech-heavy Nasdaq added 0.95%.
Coming into today, shares of the health care real estate investment trust had lost 8.04% in the past month. In that same time, the Finance sector gained 2.14%, while the S&P 500 gained 3.85%.
The investment community will be closely monitoring the performance of Medical Properties in its forthcoming earnings report. The company is expected to report EPS of $0.13, down 43.48% from the prior-year quarter. At the same time, our most recent consensus estimate is projecting a revenue of $228.55 million, reflecting a 14.26% fall from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.55 per share and revenue of $919.34 million. These totals would mark changes of -31.25% and -7.65%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Medical Properties. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, there's been a 2.35% fall in the Zacks Consensus EPS estimate. Medical Properties presently features a Zacks Rank of #3 (Hold).
Looking at valuation, Medical Properties is presently trading at a Forward P/E ratio of 7.64. This denotes a discount relative to the industry average Forward P/E of 11.41.
The REIT and Equity Trust - Other industry is part of the Finance sector. This group has a Zacks Industry Rank of 156, putting it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.